Diffuse large B-cell lymphoma’s long-term effects on immune profiles, plasminogen activation and prevention of venous thromboembolism, and PARP inhibitors in hematological malignancies carrying epigenetic mutations
This episode discusses persistent immune profile changes in diffuse large B-cell lymphoma survivors, the apparent lack of role for plasminogen activation in preventing venous thromboembolism, and a new mechanism for targeting hematological malignancies with epigenetic mutations…